4DMedical Limited Stock
Stocks
4DX
AU0000095416
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Australian S.E.
10:14:21 21/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 4.300 AUD | -0.23% |
|
+25.58% | +9.92% |
| 16/09 | Lotus Resources Most Shorted Stock on Australian Bourse, ASIC Data Shows | MT |
| 08/09 | ASX Biggest Losers | MT |
| Market Cap | 2.58B 1.84B 1.6B 1.51B 1.37B 2.57B 176B 18.12B 6.99B 89.63B 6.9B 6.75B 288B | P/E 2026 |
-151x | P/E 2027 * | -69.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.32B 1.65B 1.44B 1.36B 1.23B 2.31B 158B 16.27B 6.28B 80.46B 6.2B 6.06B 259B | EV / Sales 2026 |
344x | EV / Sales 2027 * | 103x |
| Free-Float |
93.93% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| 4DX | Delayed | |
OTC Markets
| FDMD.F | Delayed | |
|
Tradegate
| MQ7 | Real-time | |
|
Deutsche Boerse AG
| MQ7 | Delayed | |
|
Boerse Muenchen
| MQ7 | Real-time |
Last Transcript: 4DMedical Limited
| 1 day | +0.23% | ||
| 1 week | +25.58% | ||
| Current month | +26.32% | ||
| 1 month | +12.79% | ||
| 3 months | -8.47% | ||
| 6 months | -1.14% | ||
| Current year | +9.92% |
| 1 week | 3.49 |  | 4.38 |
| 1 month | 3.31 | | 4.38 |
| Current year | 2.95 | | 7.55 |
| 1 year | 1.4 | | 7.55 |
| 3 years | 0.22 | | 7.55 |
| 5 years | 0.22 | | 7.55 |
| 10 years | 0.22 | | 7.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
CEO | Chief Executive Officer | - | 01/12/2012 |
Julian Sutton
DFI | Director of Finance/CFO | - | 02/01/2026 |
Greg Mogel
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Andreas Fouras
BRD | Director/Board Member | - | 01/12/2012 |
Lilian Bianchi
CHM | Chairman | - | 02/11/2023 |
John Livingston
BRD | Director/Board Member | - | 01/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/6/26 | Buy | Chief Financial Officer | 13,054 | 0.0022% | ||
| 4/3/26 | Exercice | Director | 213,464 | 0.0373% | ||
| 4/3/26 | Exercice | Director | 213,464 | 0.0373% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.23% | +25.58% | +185.15% | +685.45% | 1.84B | |
| -1.04% | +6.83% | +35.84% | +29.03% | 241B | |
| -0.32% | +5.83% | +9.58% | -16.76% | 149B | |
| +2.55% | +6.55% | -10.35% | +34.72% | 139B | |
| -0.48% | +0.84% | -55.70% | -19.89% | 62.81B | |
| +0.01% | +4.61% | +18.61% | +22.67% | 50.87B | |
| -1.69% | -1.20% | -19.89% | -17.59% | 48.21B | |
| +0.08% | +6.49% | +23.87% | +39.12% | 44.11B | |
| -1.88% | +3.25% | +40.14% | +53.82% | 41.42B | |
| -2.27% | +16.07% | +133.21% | +73.20% | 36.18B | |
| Average | -0.48% | +7.75% | +36.05% | +88.38% | 81.42B | |
| Weighted average by Cap. | -0.26% | +5.78% | +15.95% | +19.95% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 8.34M 5.93M 5.17M 4.88M 4.43M 8.31M 569M 58.47M 22.56M 289M 22.27M 21.78M 931M | 22.8M 16.21M 14.13M 13.35M 12.12M 22.71M 1.56B 160M 61.69M 791M 60.89M 59.53M 2.54B |
| Net income | -177M -126M -110M -104M -94.1M -176M -12.08B -1.24B -479M -6.14B -473M -462M -19.76B | -38.5M -27.37M -23.87M -22.53M -20.46M -38.34M -2.63B -270M -104M -1.34B -103M -101M -4.3B |
| Net Debt | -264M -188M -164M -155M -141M -263M -18.04B -1.85B -716M -9.17B -706M -691M -29.51B | -236M -168M -146M -138M -126M -235M -16.11B -1.66B -639M -8.19B -631M -617M -26.36B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/09/26 | $4.300 | -0.23% | 904,382 |
| 18/09/26 | $4.310 | +13.42% | 11,444,538 |
| 17/09/26 | $3.800 | +7.34% | 4,239,754 |
| 16/09/26 | $3.540 | -5.35% | 2,932,965 |
| 15/09/26 | $3.740 | +8.72% | 5,370,439 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4DX Stock
Select your edition
All financial news and data tailored to specific country editions
